Multi-Analyte Controls, All Kinds (Assayed)(JJY)

多項目コントロール(検査値表示) この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。

米国回収

91 件

直近 2025.11.26

510(k)

673 件

PMA

0 件

不具合報告

121 件

分類情報

Product Code JJY
デバイス名 Multi-Analyte Controls, All Kinds (Assayed)

多項目コントロール(検査値表示) この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。

デバイスクラス クラス I
21 CFR 規制番号 862.1660
審査区分 届出免除(510(k) Exempt)
医療専門分野 臨床化学
定義 -
フラグ
該当なし
AI分析

本品は、臨床化学検査において複数の測定項目を同時に精度管理するために用いられる、あらかじめ既知の分析値が付与された多項目コントロール血清です。米国FDAの規制上はクラスIに分類され、リスクが低いことから510(k)による市販前届出が免除される機器として位置づけられています。

米国市場での動向

本製品は510(k)届出免除対象のクラスI医療機器で、これまでに約670件の510(k)が届出され、167社が参入していますが、直近5年間の届出はなく、最新の判定は2017年3月です。不具合報告は累計約120件で、その内訳は死亡0件、傷害約20件、不具合(Malfunction)約80件、その他約20件と、不具合報告が中心となっています。主な問題としては、Improper or Incorrect Procedure or Method(不適切または誤った手順・方法)、Use of Device Problem(機器使用に関する問題)、Burst Container or Vessel(容器の破裂)が挙げられています。回収は累計約90件で、クラスIは確認されていませんが、クラスIIが約50件、クラスIIIが約30件を占め、直近5年間では約20件の回収があり、最新の回収は2025年10月に開始されています。

この分析は公開データ(openFDA・JMDN 対応情報)をもとに AI が生成した参考情報です。市場データは2026年8月時点の集計に基づきます。

関連 product code

同じ 21 CFR 862.1660 に分類される product code(12 件)

No.product code機器名クラス専門分野510(k)PMA不具合回収
1JJX

Single (Specified) Analyte Controls (Assayed And Unassayed)

単一(特定)分析物コントロール(値付き・未値付き)

I臨床化学493—67142 件
2JJT

Enzyme Controls (Assayed And Unassayed)

酵素コントロール(値付け及び非値付け)

I臨床化学97—182 件
3JJS

Controls For Blood-Gases, (Assayed And Unassayed)

血液ガス分析用コントロール(値付け・値なし)

I臨床化学67—31 件
4JJW

Urinalysis Controls (Assayed And Unassayed)

尿検査用コントロール(値付き及び値なし)

I臨床化学61—3122 件
5JJR

Electrolyte Controls (Assayed And Unassayed)

電解質コントロール(値付け・非値付け)

I臨床化学17—2—
6LCH

Tonometer (Calibration And Q.C. Of Blood-Gas Instruments), Clinical

血液ガス機器校正・精度管理用臨床トノメーター

I臨床化学9——2 件
7MJX

Kit, Serological, Positive Control

血清学的検査用陽性対照キット

I臨床化学7—21 件
8MJZ

Kit, Direct Antigen, Positive Control

直接抗原検出用陽性対照キット

I臨床化学3———
9MJY

Kit, Serological, Negative Control

血清学的検査用陰性コントロールキット

I臨床化学1———
10OLD

Internal Polymerase Chain Reaction Control, Not Assay Specific

内部ポリメラーゼ連鎖反応コントロール(アッセイ非特異的)

I臨床化学1———
11MKA

Kit, Direct Antigen, Negative Control

I臨床化学————
12OHQ

Multi-Analyte Controls Unassayed

多項目用未検定管理物質

I臨床化学——624 件

機器名の日本語訳は AI により自動生成したものです。正確には英語原文をご確認ください。

FDA のデバイスクラスは 3 段階(クラス I〜III)、日本の医療機器は 4 段階(クラス I〜IV)で分類されており、 1 対 1 では対応しません。 リスク区分の考え方が異なるため、参考情報としてご利用ください。

米国での回収・承認・不具合報告

無料会員 1,000名 突破

回収・承認・不具合報告の明細の閲覧は会員限定です

無料で会員登録する
回収番号クラス回収開始日企業理由ステータス
Z-0538-2026 JJYクラス III(軽微)2025.10.06POLYMEDCO, INC. / POLYMEDCO CANCER DIAGNOSTIC PRODUCTS, LLC

A labeling error was identified on the affected product. The expiration date on the kit box label and on the vial labels incorrectly stated the expiration date as 2026-01-16. The correct expiration date should be 2027-01-17.

対応中
Z-0415-2026 JJYクラス II2025.10.01Microgenics Corporation

The firm received complaints from customers reporting vial-to-vial variability when using the control with high sensitivity Troponin I assays. This defect may lead to as delay in patient results for hs Troponin I assays.

対応中
Z-1839-2025 JJYクラス II2025.04.24Mckesson Medical-Surgical Inc. Corporate Office

transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

対応中
Z-1838-2025 JJYクラス II2025.04.24Mckesson Medical-Surgical Inc. Corporate Office

transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

対応中
Z-1824-2025 JJYクラス II2025.04.24Mckesson Medical-Surgical Inc. Corporate Office

transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

対応中
Z-1373-2024 JJYクラス II2024.02.27Ortho-Clinical Diagnostics

The issue was mismatched diluent lots assembled into VITRO Chemistry Products Performance Verifier I and II. This issue has the potential to cause erroneous Quality Control (QC) results that could lead to testing delays and erroneous patient results. This issue caused positive or negative bias in the quantification of sodium (Na+) and total carbon dioxide (ECO2). The incorrect diluent into the Performance Verifier II exhibited a potential negative bias of up to 6 mmol/L for ECO2 and Na+ testing.

対応中
Z-1372-2024 JJYクラス II2024.02.27Ortho-Clinical Diagnostics

The issue was mismatched diluent lots assembled into VITRO Chemistry Products Performance Verifier I and II. This issue has the potential to cause erroneous Quality Control (QC) results that could lead to testing delays and erroneous patient results. This issue caused positive or negative bias in the quantification of sodium (Na+) and total carbon dioxide (ECO2). The incorrect diluent into the Performance Verifier II exhibited a potential negative bias of up to 6 mmol/L for ECO2 and Na+ testing.

対応中
Z-1315-2024 JJYクラス II2024.01.09Mckesson Medical-Surgical Inc. Corporate Office

Facility Critical Temperature Excursions on 08-JAN 2024 in Walk-In refrigerator due to mechanical failures, causing temperatures to fall below the validated range of 35.6 - 46.4 Degrees Fahrenheit (2 - 8 Degrees Celsius) for up to 60 minutes which could increase the probability of an incorrect test result or a delayed test result.

対応中
Z-1314-2024 JJYクラス II2024.01.09Mckesson Medical-Surgical Inc. Corporate Office

Facility Critical Temperature Excursions on 08-JAN 2024 in Walk-In refrigerator due to mechanical failures, causing temperatures to fall below the validated range of 35.6 - 46.4 Degrees Fahrenheit (2 - 8 Degrees Celsius) for up to 60 minutes which could increase the probability of an incorrect test result or a delayed test result.

対応中
Z-0106-2024 JJYクラス II2023.08.25TECHNO-PATH MANUFACTURING LTD.

Technopath Manufacturing Ltd. has identified an issue with the glass vial commodity used to fill the Multichem S Plus Level 1, Multichem S Plus Level 2, Multichem S Plus Level 3, Multichem IA Plus and Multichem P Controls. Some customers have experienced broken vials when receiving or thawing Technopath Multichem IA Plus and Multichem S Plus Controls. Breakages have been observed upon delivery, while thawing or while opening the vial. The breakages can result in the bottom of the vial breaking off, breakage in the neck thread area or cracking on the sides of the vial. This may expose the user to biohazardous material if cut and may cause a delay in patient results.

対応中
Z-0105-2024 JJYクラス II2023.08.25TECHNO-PATH MANUFACTURING LTD.

Technopath Manufacturing Ltd. has identified an issue with the glass vial commodity used to fill the Multichem S Plus Level 1, Multichem S Plus Level 2, Multichem S Plus Level 3, Multichem IA Plus and Multichem P Controls. Some customers have experienced broken vials when receiving or thawing Technopath Multichem IA Plus and Multichem S Plus Controls. Breakages have been observed upon delivery, while thawing or while opening the vial. The breakages can result in the bottom of the vial breaking off, breakage in the neck thread area or cracking on the sides of the vial. This may expose the user to biohazardous material if cut and may cause a delay in patient results.

対応中
Z-0104-2024 JJYクラス II2023.08.25TECHNO-PATH MANUFACTURING LTD.

Technopath Manufacturing Ltd. has identified an issue with the glass vial commodity used to fill the Multichem S Plus Level 1, Multichem S Plus Level 2, Multichem S Plus Level 3, Multichem IA Plus and Multichem P Controls. Some customers have experienced broken vials when receiving or thawing Technopath Multichem IA Plus and Multichem S Plus Controls. Breakages have been observed upon delivery, while thawing or while opening the vial. The breakages can result in the bottom of the vial breaking off, breakage in the neck thread area or cracking on the sides of the vial. This may expose the user to biohazardous material if cut and may cause a delay in patient results.

対応中
Z-2609-2023 JJYクラス II2023.08.03Randox Laboratories Ltd.

there has been a transcription error in the Instructions for Use (IFU) for the Liquid Assayed Chemistry Control Premium Plus Level 3. For Caeruloplasmin, the one and two standard deviation values printed on the sheet are incorrect, which may lead to misreporting patient results. Target and range values are correct, and risk is mitigated; most clinical labs will use the target and range values in clinical practice.

対応中
Z-2446-2023 JJYクラス II2023.06.21Randox Laboratories Ltd.

(1) There is vial to vial variation resulting in some vials recovering positive for hCG, which should be negative and (2) high and outside range for cortisol. (3) There has been a transcription error for Creatinine in the Instructions For Use (IFU). The target and ranges for Creatinine for the Roche Creatinine Plus method have been listed incorrectly. These failures cause a delay in patient results for the above mentioned analytes.

対応中
Z-2022-2023 JJYクラス III(軽微)2023.05.04Randox Laboratories Ltd.

Delay in reporting results due to Quality Controls running high outside of range. Target value and range for ACTH in Immunoassay Premium Level 3, IA2640, lot 2031EC and Immunoassay Premium Control Tri Level kit batch 583135 lot 2031EC has been reassigned on the Roche Cobas e801 due to High recovery outside range

対応中
Z-2021-2023 JJYクラス III(軽微)2023.05.04Randox Laboratories Ltd.

Delay in reporting results due to Quality Controls running high outside of range. Target value and range for ACTH in Immunoassay Premium Level 3, IA2640, lot 2031EC and Immunoassay Premium Control Tri Level kit batch 583135 lot 2031EC has been reassigned on the Roche Cobas e801 due to High recovery outside range

対応中
Z-0905-2023 JJYクラス II2022.11.22Randox Laboratories Ltd.

Concentration of Rheumatoid Factor has decreased in Specific Protein Control Level 1-3 causing delay in reporting results due to Quality Controls running low outside range

対応中
Z-0904-2023 JJYクラス II2022.11.22Randox Laboratories Ltd.

Concentration of Rheumatoid Factor has decreased in Specific Protein Control Level 1-3 causing delay in reporting results due to Quality Controls running low outside range

対応中
Z-0903-2023 JJYクラス II2022.11.22Randox Laboratories Ltd.

Concentration of Rheumatoid Factor has decreased in Specific Protein Control Level 1-3 causing delay in reporting results due to Quality Controls running low outside range

対応中
Z-1337-2022 JJYクラス II2022.05.19Chromsystems Instruments & Chemicals GmbH

Too low concentration of glycine was detected in the dried blood controls of the batch 2821 of the products.

終了

510(k)(市販前届出)

全 673 件
No.番号機器名申請者決定日種別概要
1K162530 Multichem IA PlusTechno-Path Manufacturing2017.03.31簡略(Abbreviated) PDF
2K163629 Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.2017.03.10通常(Traditional) PDF
3K163015 Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2; Liquichek Tumor Marker Control-Level 3; Liquichek Tumor Marker Control- Trilevel MiniPakBio-Rad Laboratories2017.01.10通常(Traditional) PDF
4K153712 VK-3 Verification Kit, VK-4 Verification Kit, VK-R5 Verification Kit, VK-R7 Verification Kit, VK-Crea Verification KitRadiometer America, Inc.2016.01.28通常(Traditional) PDF
5K150300 Liquichek Cardiac Markers Plus Control LTBio-Rad Laboratories2015.12.11通常(Traditional) PDF
6K142964 VALIDATE Anemia Calibration Verification/ Linearity Test KitMaine Standards Company, LLC2015.04.30通常(Traditional) PDF
7K143379 Liquichek Maternal Serum II ControlBio-Rad Laboratories2015.03.13通常(Traditional) PDF
8K143573 Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.2015.01.16通常(Traditional) PDF
9K140971 LIQUID ASSAYED CHEMISTRY CONTROL PREMIUM PLUS LEVEL 1,2 AND LEVEL 3.Randox Laboratories Limited2014.12.08通常(Traditional) PDF
10K142978 Audit MicroControls Linearity LQ Special DiabetesAalto Scientific, Ltd.2014.11.20通常(Traditional) PDF
11K133676 ABX PENTRA MICRO ALB CONTROL L/HHORIBA ABX SAS2014.07.11簡略(Abbreviated) PDF
12K141073 LIQUICHEK TUMOR MARKER CONTROLBio-Rad Laboratories2014.06.23通常(Traditional) PDF
13K140522 RANDOX IMMUNOASSAY PREMIUM PLUS CONTROL LEVELS 1,2 AND LEVEL 3 AND IMMUNOASSAY PREMIUM PLUS TRI-LEVEL CONTROLRandox Laboratories Limited2014.05.22通常(Traditional) PDF
14K140916 LIQUICHEK CARDIAC TROPONINS CONTROL, LEVELS 1,2 AND 3, TRILEVEL/MINIPAKBio-Rad Laboratories2014.05.06通常(Traditional) PDF
15K140764 LIQUICHEK IMMUNOLOGYCONTROL-LEVEL 1,LEVEL 2, LEVEL 3, MINIPAKBio-Rad Laboratories2014.04.25通常(Traditional) PDF
16K134013 LYPHOCHEK ALLERGEN SIGE CONTROL, NEGATIVE, LYPOCHEK ALLERGEN SIGE CONTROL, NEGATIVE MINIPAK, LYPHOCHEK ALLERGEN SIGE COBio-Rad Laboratories2014.04.24通常(Traditional) PDF
17K140393 RANDOX AMMONIA ETHANOL CONTROL LEVELS 1, 2 AND LEVEL 3Randox Laboratories Limited2014.03.25通常(Traditional) PDF
18K133960 LYPOCHEK SPECIALTY IMMUNOASSAY CONTROLBio-Rad Laboratories2014.01.22通常(Traditional) PDF
19K132227 LIQUICHEK IMMUNOASSAY PREMIUM CONTROL-TRILEVEL, LIQUICHEK IMMUNOASSAY PREMIUM CONTROL-LEVEL I, LIQUICHEK IMMUNOASSAYBio-Rad Laboratories2013.10.25通常(Traditional) PDF
20K132156 RANDOX CSF CONTROLS LEVELS 2 AND 3Randox Laboratories, Ltd.2013.10.23通常(Traditional) PDF

出典の openFDA は各 510(k) の主要(primary)product code のみを収録しているため、副次コードを含む FDA 公式データベースの検索結果とは件数が異なる場合があります。 FDA 510(k) データベースで確認

PMA(市販前承認)

この product code の PMA 情報はありません。

不具合報告(MAUDE)トレンド

米国不具合報告検索で詳しく見る

出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。

報告の存在は、機器と事象の因果関係を意味しません。報告件数を機器間の不具合発生率の比較に用いることはできません。

各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。

不具合報告データを読み込み中...

出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。

取得日: 2026.09.28

各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。